Marina Natoli

11PUBLICATIONS
66CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tissue engineeringTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Sep 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer.

Irene Fusi, Clara Serger, Petra Herzig

|Aug 04, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release.

Miguel Gaspar, Marina Natoli, Laure Castan

|Nov 01, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.

Marina Natoli, Klas Hatje, Pratiksha Gulati

|Jul 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity.

Nicole Kirchhammer, Marcel P Trefny, Marina Natoli

|Feb 08, 2022
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.

Pavlina Spiliopoulou, Sarah Spear, Hasan Mirza

Pageof 2

Frequent Collaborators

5 joint publications

Alfred Zippelius

4 joint publications

Sadaf Ghaem-Maghami

3 joint publications

Heinz Läubli

2 joint publications

Henry Kao